Article Details
Retrieved on: 2025-06-25 17:15:17
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
From EAN 2025: Real-world EUREkA study findings have shown sustained 2-year effectiveness with anti-CGRP monoclonal antibodies for the treatment ...
Article found on: www.springermedicine.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here